CJC-1295 + Ipamorelin (10 mg + 5 mg) — Research Overview
This blend pairs CJC-1295 and Ipamorelin — the most widely studied growth hormone secretagogue combination — in a single 10 mg + 5 mg vial. It is a cornerstone of GH peptide research in Canada.
Mechanism & Research Applications
The two compounds work through complementary pathways: CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue with an extended half-life, while Ipamorelin is a selective ghrelin receptor agonist. Together they are studied for amplified, pulsatile GH release that mimics youthful secretion patterns.
A pre-combined vial simplifies protocols that would otherwise require reconstituting and dosing two compounds separately.
Specifications
CJC-1295 10 mg + Ipamorelin 5 mg | ≥99% purity per component (HPLC-verified) | Batch-specific COA included
Quality & Sourcing in Canada
NuMe supplies CJC-1295 + Ipamorelin (10 mg + 5 mg) as part of its catalogue of research peptides in Canada and buy peptides in Canada. Every batch is verified to ≥99% purity by HPLC, ships domestically from within Canada (typically 1–3 business days), and includes a batch-specific Certificate of Analysis. Free shipping applies to orders over $300 CAD.
Frequently Asked Questions
Why combine CJC-1295 and Ipamorelin?
Their mechanisms are complementary — a GHRH analogue plus a ghrelin receptor agonist — which is why they are the most studied GH secretagogue pairing in the research literature.
What are the quantities in this blend?
This vial contains 10 mg of CJC-1295 and 5 mg of Ipamorelin, each HPLC-verified to ≥99% purity with a batch-specific COA.
Does this ship within Canada?
Yes, domestically from a Canadian facility, typically in 1–3 business days. For research use only.
For Research Purposes Only. This product is intended exclusively for laboratory research and in-vitro testing. It is not for human or veterinary use, consumption, or any therapeutic application.
Reviews
There are no reviews yet.